Paul Tudor Jones’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,500
Closed -$231K 4276
2025
Q4
$231K Sell
10,500
-3,400
-24% -$61.4K ﹤0.01% 3209
2025
Q3
$169K Buy
+13,900
New +$188K ﹤0.01% 3222

Other funds holding TNDM

Paul Tudor Jones's TNDM Position: Q2 2026 in Review

Paul Tudor Jones increased its Tandem Diabetes Care (TNDM) stake by 359% in Q2 2026, buying an estimated $4.95M and bringing the position to 362,708 shares worth $5.47M. The position accounts for 0.01% of the portfolio, ranked #1225.

Paul Tudor Jones first reported a position in TNDM in Q4 2013 and has held it in 21 quarters since. The position peaked at $7.77M in Q1 2025. 272 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Paul Tudor Jones held 362,708 shares of Tandem Diabetes Care worth $5.47M as of Q2 2026.
  • Paul Tudor Jones bought 283,709 Tandem Diabetes Care shares in Q2 2026, an estimated $4.95M.
  • Tandem Diabetes Care made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1225 holding.
  • Paul Tudor Jones first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 21 quarters since.
  • Paul Tudor Jones's Tandem Diabetes Care position peaked at $7.77M in Q1 2025.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.